eNauka - pregled
Pregled prema Autor Ceric, Timur
Prikaz rezultata 1 do 6 od 6
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2021 | A phase Ib/II study of the dual MDMX/MDM2 inhibitor, ALRN-6924, for the prevention of chemotherapy-induced myelosuppression![]() | Andric, Zoran G | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2019 | AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan)![]() | Todorovic, Vladimir; ...; Babovic, Nada Lj; ...; Četniković, Bojana; Ceric, Timur; ...; Dzamic, Zoran M
...; Knežević-Ušaj, Slavica F
| Naučni članak | 23M23 - Međunarodni časopis kategorije M23 |
| 2023 | Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers![]() | Miletic, Dragana; Kraljevic, Marija; Sokolovic, Emir; Soce, Majana; Milovic-Kovacevic, Marijana M | Naučni članak | 22M22 - Međunarodni časopis kategorije M22 |
| 2014 | Galaxy-2 trial (NCT01798485): A randomized phase 3 study of ganetespib itt combination with docetaxel versus docetaxel alone in patients with advanced lung adenocarcinoma. | Ramalingam, Suresh S; Zaric, Bojan | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2020 | Prevention of Chemotherapy-induced Myelosuppression in SCLC patients treated with the Dual MDMX/MDM2 Inhibitor ALRN-6924![]() | Andric, Zoran G | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2012 | Quality of Life Analysis in the Galaxy Trialtm (Nct01348126): a Randomized Phase Iib/Iii Study of Ganetespib (Sta-9090) in Combination with Docetaxel Versus Docetaxel Alone in Patients with Stage Iiib Or Iv Nsclc | Andric, Zoran G | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
